‘A very American company,’ says AstraZeneca CEO as Trump seals drug pricing pact
President Trump has made a deal with AstraZeneca to lower drug prices for Medicaid patients in exchange for tariff relief. This follows a similar deal with Pfizer and aligns with the White House's goal of reducing drug prices. AstraZeneca will offer discounts through TrumpRx and receive a tariff exemption.